Hepatitis C Spending Breaking the Medicare Part D Bank
investigativeeconomics.substack.com
A 2016 report by Health and Human Service’s Office of the Inspector General lists the hepatitis C medication, Harvoni, as the largest expense for Medicare Part D’s catastrophic coverage in 2015. Another hepatitis C drug, Sovaldi, also made by Gilead Sciences was the third largest. Together they accounted for over $7.4 billion in spending on catastrophic coverage that year. Catastrophic drug coverage accounts for 80% of all drug spending.
Hepatitis C Spending Breaking the Medicare Part D Bank
Hepatitis C Spending Breaking the Medicare…
Hepatitis C Spending Breaking the Medicare Part D Bank
A 2016 report by Health and Human Service’s Office of the Inspector General lists the hepatitis C medication, Harvoni, as the largest expense for Medicare Part D’s catastrophic coverage in 2015. Another hepatitis C drug, Sovaldi, also made by Gilead Sciences was the third largest. Together they accounted for over $7.4 billion in spending on catastrophic coverage that year. Catastrophic drug coverage accounts for 80% of all drug spending.